Minimal residual disease testing in a clinical trial for acute leukemia

Ended Awarded Last action

Contract number
75N91018F00061
Awardee
Awarding agency
Obligated
$3,108,907

Award facts

Contract value 100% obligated
$3,108,907.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
561210 Facilities Support Services
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $3,108,907

About this award

The Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute awarded a Cost Plus Fixed Fee delivery order contract to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., to provide minimal residual disease testing in support of a clinical trial for acute leukemia. The contract has a potential value of $3,108,907.00 and a completion date of September 23, 2023. Leidos Biomedical Research has a long history of supporting federal biomedical research efforts through prime and subcontract awards from the NIH and other agencies, including work in areas such as cancer, HIV/AIDS, and COVID-19 research. This award is not associated with a set-aside program.

Quick answers

Who was awarded contract 75N91018F00061?

75N91018F00061 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 24, 2018.

How much is contract 75N91018F00061 worth?

The government has obligated $3,108,907 on 75N91018F00061.

Is contract 75N91018F00061 an order under another contract?

Yes. 75N91018F00061 is a delivery order under HHSN261201500003I, an indefinite delivery contract.

Was contract 75N91018F00061 competed?

The extent of competition for 75N91018F00061 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award